Ingried Saam

Title: Ingried Saam: Innovator in Thymocyte Research

Introduction

Ingried Saam is a notable inventor based in Bernried, Germany. He has made significant contributions to the field of immunology through his innovative research and patented methods. His work focuses on the production of thymocyte supernatant, which has implications for various medical applications.

Latest Patents

Ingried Saam holds a patent for a "Method for the production of thymocyte supernatant." This patent describes a process that involves co-cultivating thymocytes and mononuclear cells at a specific cell ratio in the presence of phorbol-12-myristate-13-acetate and Phytohemagglutinin M for up to 60 hours. The method culminates in the separation of the co-cultivation medium from the cells, resulting in the production of thymocyte supernatant. He has 1 patent to his name.

Career Highlights

Saam is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His role at the company allows him to further his research and contribute to advancements in medical science.

Collaborations

Throughout his career, Ingried Saam has collaborated with talented individuals, including Sonja Offner and Markus Horvath. These collaborations have enriched his research and fostered innovation in his field.

Conclusion

Ingried Saam's work in thymocyte research exemplifies the impact of innovative methods in the medical field. His contributions continue to pave the way for advancements in immunology and related disciplines.